首页> 美国卫生研究院文献>Therapeutic Advances in Chronic Disease >Use of nonselective β blockers after variceal eradication incirrhotic patients undergoing secondary prophylaxis of esophageal varicealbleeding: a critical review of current evidence
【2h】

Use of nonselective β blockers after variceal eradication incirrhotic patients undergoing secondary prophylaxis of esophageal varicealbleeding: a critical review of current evidence

机译:根除静脉曲张后非选择性β受体阻滞剂的使用肝硬化患者接受食管静脉曲张继发预防出血:对当前证据的严格审查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nonselective β blockers (NSBBs) combined with esophageal variceal ligation (EVL) are recommended for secondary prophylaxis of esophageal variceal bleeding (EVB) in cirrhotic patients according to the current practice guidelines and consensus. However, until now, there is a paucity of recommendations regarding the use of NSBBs in cirrhotic patients who achieved variceal eradication. In this review paper, we firstly introduced a case who achieved variceal eradication after additional use of NSBBs for secondary prophylaxis of EVB and then did not require further endoscopic therapy during repeated endoscopic surveillance, and subsequently discuss the importance of NSBBs for secondary prophylaxis of EVB, the effect of NSBBs after variceal eradication, adherence to NSBBs, screening for variceal recurrence, and timing of endoscopic surveillance after variceal eradication.
机译:根据目前的操作指南和共识,建议对肝硬化患者进行食道静脉曲张结扎(EVL)的非选择性β受体阻滞剂(NSBBs)的继发预防。但是,到目前为止,关于在根除静脉曲张的肝硬化患者中使用NSBBs的建议很少。在这篇评论文章中,我们首先介绍了一个案例,该案例在额外使用NSBBs进行EVB的二级预防后,实现了根除静脉曲张,然后在反复内窥镜监测期间不需要进一步的内镜治疗,随后讨论了NSBBs在EVB的二级预防中的重要性,根除静脉曲张后NSBBs的效果,对NSBBs的依从性,静脉曲张复发的筛查以及根除静脉曲张后内镜监测的时机。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号